Literature DB >> 25124544

Prophylactic effect of human lactoferrin against Streptococcus mutans bacteremia in lactoferrin knockout mice.

Senthil Kumar Velusamy1, Daniel H Fine1, Kabilan Velliyagounder2.   

Abstract

Streptococcus mutans is the primary agent of dental caries, which is often detected in transient bacteremia. Lactoferrin is a multifunctional glycoprotein showing antibacterial activities against several Streptococcus species. We reported here the prophylactic effect of human lactoferrin (hLF) in a lactoferrin knockout mouse (LFKO-/-) bacteremic model. The hLF treatment significantly cleared S. mutans from the blood and organs of bacteremic mice when compared to the non-hLF treated mice. Further, analysis of serum cytokines, spleen and liver cytokine mRNA levels revealed that hLF prophylaxis modulates their release differently when compared to the non-hLF treated group. C-reactive protein level (P = 0.003) also decreased following hLF prophylaxis in S. mutans induced bacteremic mice. Additional quantitative RT-PCR analysis revealed that hLF prophylaxis significantly decreased the expression level of IFN-γ, TNF-α, IL-1β, IL-6, MPO and iNOS in spleen and liver. These results suggested that the hLF protects the host against S. mutans-induced experimental bacteremia.
Copyright © 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Bacteremia; Human lactoferrin; Prophylaxis; Streptococcus mutans

Mesh:

Substances:

Year:  2014        PMID: 25124544      PMCID: PMC4252812          DOI: 10.1016/j.micinf.2014.07.009

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  41 in total

1.  Invasion and killing of human endothelial cells by viridans group streptococci.

Authors:  Murray W Stinson; Susan Alder; Sarmishtha Kumar
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 2.  Biodefense properties of milk: the role of antimicrobial proteins and peptides.

Authors:  D A Clare; G L Catignani; H E Swaisgood
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

Review 3.  Lactoferrin and immunologic dissonance: clinical implications.

Authors:  Marian L Kruzel; Michał Zimecki
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2002       Impact factor: 4.291

4.  Biochemical and genetic characterization of serologically untypable Streptococcus mutans strains isolated from patients with bacteremia.

Authors:  T Fujiwara; K Nakano; M Kawaguchi; T Ooshima; S Sobue; S Kawabata; I Nakagawa; S Hamada
Journal:  Eur J Oral Sci       Date:  2001-10       Impact factor: 2.612

5.  Lactoferrin stimulates killing and clearance of bacteria but does not prevent mortality of diabetic mice.

Authors:  T Zagulski; Z Jarzabek; A Zagulska; M Jaszczak; I E Kochanowska; M Zimecki
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2001       Impact factor: 4.291

6.  Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice.

Authors:  M Zimecki; M L Kruzel
Journal:  Immunol Lett       Date:  2000-11-01       Impact factor: 3.685

7.  Molecular diagnosis of infective endocarditis by PCR amplification and direct sequencing of DNA from valve tissue.

Authors:  Valérie Gauduchon; Lara Chalabreysse; Jerome Etienne; Marie Célard; Yvonne Benito; Hubert Lepidi; Françoise Thivolet-Béjui; François Vandenesch
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

8.  One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis.

Authors:  Kabilan Velliyagounder; Jeffrey B Kaplan; David Furgang; Diana Legarda; Gill Diamond; Ruth E Parkin; Daniel H Fine
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  Analysis of loci required for determination of serotype antigenicity in Streptococcus mutans and its clinical utilization.

Authors:  Yukie Shibata; Kazuhisa Ozaki; Mitsuko Seki; Takayuki Kawato; Hideki Tanaka; Yoshio Nakano; Yoshihisa Yamashita
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

10.  Protective effects of human lactoferrin during Aggregatibacter actinomycetemcomitans-induced bacteremia in lactoferrin-deficient mice.

Authors:  S K Velusamy; R Poojary; R Ardeshna; Waad Alabdulmohsen; D H Fine; K Velliyagounder
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

View more
  8 in total

1.  Oral lactoferrin protects against experimental candidiasis in mice.

Authors:  K Velliyagounder; W Alsaedi; W Alabdulmohsen; K Markowitz; D H Fine
Journal:  J Appl Microbiol       Date:  2014-11-25       Impact factor: 3.772

2.  Diabetic Lactoferrin Deficient Mice Demonstrates Greater Susceptibility to Experimental Periodontal Disease.

Authors:  Waad Alabdulmohsen; Sonia D Rozario; Kenneth Markowitz; Daniel H Fine; Kabilan Velliyagounder
Journal:  J Oral Biol (Northborough)       Date:  2015-07-02

3.  Antibacterial and Anti-biofilm Activity of the Human Breast Milk Glycoprotein Lactoferrin against Group B Streptococcus.

Authors:  Jacky Lu; Jamisha D Francis; Miriam A Guevara; Rebecca E Moore; Schuyler A Chambers; Ryan S Doster; Alison J Eastman; Lisa M Rogers; Kristen N Noble; Shannon D Manning; Steven M Damo; David M Aronoff; Steven D Townsend; Jennifer A Gaddy
Journal:  Chembiochem       Date:  2021-03-23       Impact factor: 3.461

4.  Combined analysis of the salivary microbiome and host defence peptides predicts dental disease.

Authors:  A Simon-Soro; A Sherriff; S Sadique; G Ramage; L Macpherson; A Mira; S Culshaw; J Malcolm
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

Review 5.  Endogenous antimicrobial factors in the treatment of infectious diseases.

Authors:  Paulina Żelechowska; Justyna Agier; Ewa Brzezińska-Błaszczyk
Journal:  Cent Eur J Immunol       Date:  2017-01-24       Impact factor: 2.085

6.  VEN-120, a Recombinant Human Lactoferrin, Promotes a Regulatory T Cell [Treg] Phenotype and Drives Resolution of Inflammation in Distinct Murine Models of Inflammatory Bowel Disease.

Authors:  Christopher F MacManus; Colm B Collins; Tom T Nguyen; Randall W Alfano; Paul Jedlicka; Edwin F de Zoeten
Journal:  J Crohns Colitis       Date:  2017-09-01       Impact factor: 9.071

7.  SNP Analysis of Caries and Initial Caries in Finnish Adolescents.

Authors:  Teija Raivisto; AnnaMaria Heikkinen; Leena Kovanen; Hellevi Ruokonen; Kaisa Kettunen; Taina Tervahartiala; Jari Haukka; Timo Sorsa
Journal:  Int J Dent       Date:  2018-04-23

8.  Lactoferrin versus Long-Acting Penicillin in Reducing Elevated Anti-Streptolysin O Titer in Cases of Tonsillopharyngitis.

Authors:  Aida Ahmed Abdelmaksoud; Asmaa Nafady; Shamardan Ezzeldin Sayed Bazeed; Mahmoud Khalefa; Mahmoud K Elsamman; Mennatallah Ali Abdelrhman Sayed; Heba Mohammad Qubaisy; Ali A Ghweil; Zaki F Aref
Journal:  Infect Drug Resist       Date:  2022-09-06       Impact factor: 4.177

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.